A low Vitamin D disease, if unsupplemented, leads to many problems, e.g. death (Psoriasis in this case)
Double the risk of death if Psoraisis and low Vitamin D - Sept 2025
Associations of serum 25-hydroxyvitamin D concentrations with risks of mortality and cardiovascular disease among individuals with psoriasis
J Am Acad Dermatol 2025 Sep;93(3):678-688. doi: 10.1016/j.jaad.2025.05.1380 PDF is behind paywall
Kaiqing Lin 1, Ya Miao 1, Lu Gan 1, Bin Zhao 1, Fang Fang 2, Ru Wang 3, Xiang Chen 4, Jiaqi Huang 5

Background: Evidence remains scarce regarding the relationship between serum 25-hydroxyvitamin D (25(OH)D) and the risk of mortality and cardiovascular disease (CVD) in psoriasis.
Objective: To explore the potential protective effect of serum 25(OH)D on the risk of mortality and CVD among patients with psoriasis.
Methods: This cohort study included 8947 psoriasis patients and 178,937 controls identified at baseline in the UK Biobank cohort. Serum 25(OH)D levels were prospectively collected at the time of recruitment. Multivariable-adjusted Cox proportional hazards regression models were used to evaluate the associations between levels of serum 25(OH)D and risk of overall mortality and CVD incidence.
Results: Compared to the lowest level of serum 25(OH)D (<25 nmol/L), hazard ratios were 0.54 and 0.78 for overall mortality and incident CVD for the highest level of serum 25(OH)D (≥50 nmol/L) among psoriasis patients, respectively (all P < .05). Psoriasis patients with serum 25(OH)D ≥ 50 nmol/L appeared to have no excess risk of mortality and CVD incidence, compared with matched controls.
Limitations: Information on psoriasis subtypes was not available.
Conclusion: A higher level of serum 25(OH)D was associated with a reduced risk of overall mortality and CVD in individuals with psoriasis.
See related in VitaminDWiki
-
People die sooner if they have low vitamin D